Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-01-05 @ 5:40 AM
Study NCT ID:
NCT03091192
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-15
First Post:
2017-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Savolitinib vs. Sunitinib in MET-driven PRCC.
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-02-09
First Submit QC Date:
None
Study First Post Date:
2017-03-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-06-22
Results First Submit QC Date:
None
Results First Post Date:
2020-07-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-09-15
Last Update Post Date Type:
ESTIMATED